This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Type 1 Diabetes Mellitus
and you are
between 4 and 11
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

To determine whether insulin glulisine decreases the breakfast post prandial glycemic excursion in comparison to insulin aspart.

Provided treatments

  • Drug: insulin glulisine
  • Drug: insulin aspart
Tris trial is registered with FDA with number: NCT00913497. The sponsor of the trial is Spectrum Health Hospitals and it is looking for 16 volunteers for the current phase.
Official trial title:
Phase 4 Crossover Study Comparing the Effect of Insulin Glulisine to Insulin Aspart on Breakfast Post Prandial Blood Glucose Levels in Prepubertal Children With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy